DustyKat
Super Moderator
- Joined
- May 8, 2010
- Messages
- 25,160
As the title suggests what I am looking for is in your experience what sort of questions should I ask the GI when switching up from Azathioprine class of drugs to the biologics?
I am in the process of formulating an email for the IBD nurse/GI before our next appointment on the 4th June. Thus far I have:
I have also listed Anti MAP therapy and EEN as topics for discussion.
Any input would be most welcome.
Thanks,
Dusty. xxx
I am in the process of formulating an email for the IBD nurse/GI before our next appointment on the 4th June. Thus far I have:
- Is there any advantage to Remicade over Humira and vice versa aside from their mode of delivery and scheduling.
- Are they better used as a monotherapy or as a combined therapy.
- If using as a combined therapy what is the preferred immunomodulator given Matt's lymphocyte count and the added risks given his age and sex. Does the fact that he has already been on Imuran mean that the higher risks remain now regardless of future treatments.
- How will his progress be monitored both clinically and for the efficacy of the drug used.
I have also listed Anti MAP therapy and EEN as topics for discussion.
Any input would be most welcome.
Thanks,
Dusty. xxx